This caught my eye, it gave an honest view of biologics.
Those still taking the biologics, he says, "still suffered from some degree of pain, morning stiffness, and have a reduced quality of life."
But those who stopped the drug reported "significantly worse scores" for fatigue, pain, and quality of life measures, he says. They also lost more work time and had more impairment in daily activities, he says, but the differences in this area did not reach statistical significance.
The findings suggest that RA patients' medical needs are not being totally met, Tang says. Centocor supported the study.
I agree, RA patients' needs are not being totally met, but I am encouraged and hopeful of the ongoing research and the drug choices we do have.